SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently experiencing high volatility driven by intense speculation regarding potential bearish positions, while many investors remain focused on the company's long-term growth as a key player in AI infrastructure. Community sentiment remains deeply divided, with many traders discussing potential short squeezes and institutional accumulation while others debate the accuracy of viral rumors regarding the stock's valuation and market positioning.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and significant trading volume as investors react to a strong quarterly earnings report featuring record revenue and raised forward guidance. The community is deeply divided, with bulls pointing to the company's growth trajectory and massive short interest as a potential catalyst for a short squeeze, while skeptical traders remain cautious about continued cash burn and market manipulation concerns.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme negative sentiment and volatility as investors brace for earnings, with community members fiercely debating whether the stock is a deep-value opportunity or a failing company heading for single-digit prices. Market participants are intensely focused on signs of institutional accumulation versus potential insider weakness, creating a highly speculative environment ahead of the results.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is facing significant downward pressure as investors react to a disappointing quarterly earnings report, with the company struggling to maintain growth for its core beverage brand amid intense market competition. The stock has seen a sharp sell-off as community members debate whether this is a structural failure or a temporary setback that offers a long-term accumulation opportunity.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares faced a significant sell-off after the company reported a slight revenue miss and issued Q3 guidance that fell short of Wall Street's elevated growth expectations. While many in the community argue the nearly 20% drop is an emotional overreaction given the company's strong underlying profitability and 53% year-over-year revenue growth, others warn that the stock's premium valuation is being reset as investors grow concerned about slowing momentum and increased competition.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility following a quarterly earnings report that featured a revenue beat and raised full-year guidance, yet triggered a sharp sell-off. The community remains deeply divided between long-term investors pointing to strong store expansion and transaction growth, and skeptics citing high valuation multiples and concerns over the impact of consumer spending pressure.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing a significant post-earnings sell-off as investors react to margin compression from product mix shifts and rising costs, leading to community debates over the company's high valuation and ongoing share-based compensation practices. While some long-term investors highlight the company's dominant market position and recurring software revenue as a buying opportunity, others are actively trading against the stock, citing concern over executive selling and the broader volatility of high-multiple software holdings.

Chime Financial, Inc. engages in the design and development of a digital banking application. Its mobile app, Chime, provides online banking, fee-free overdraft, mobile banking, automatic savings, mobile payments, and security and control capabilities. The company was founded by Christopher R. Britt and Ryan King in 2012 and is headquartered in San Francisco, CA.

Chime Financial Inc - Ordinary Shares - Class A

Chime Financial, Inc.

Chime Financial is seeing active community debate as the stock experiences significant volatility following its IPO, with investors weighing concerns over post-IPO lockup expirations and sector-wide sentiment against bullish arguments for its growth metrics and fee-free model. Traders are closely monitoring the stock's technical support levels while speculating on upcoming earnings to determine if current price action represents a capitulation or a deeper correction.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending following a strong quarterly earnings report that featured record revenue and improved gross margins, fueling significant community excitement about the company's commercial execution. Investors are actively discussing the potential for a short squeeze and an upward revision of financial guidance, while also highlighting the company's expanding oncology pipeline and the relative strength of their commercial ramp compared to sector peers.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is experiencing heightened community interest and price volatility as traders closely monitor whale accumulation patterns and speculation surrounding potential legislative catalysts like the Clarity Act. While long-term supporters continue to advocate for the project's technological foundation and accumulation strategy, others express frustration with the lack of price appreciation and recent network-related sentiments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oscar Health is experiencing strong momentum, trading near 52-week highs following an upgrade from Barclays and positive sentiment surrounding its ACA marketplace exposure and margin recovery. The community is actively debating the stock's long-term growth potential and fundamental health, with many traders focused on the significance of the stock reclaiming the $30 level and its trajectory toward higher price targets.

OSCR gapped up after reporting strong Q2 earnings with revenue up 70% YoY and EPS far above estimates, but the stock reversed sharply lower as investors focused on a higher medical loss ratio, rising medical costs, and a decline in membership. The sell-off appeared driven by concerns that the improving margins may not be durable, despite the company raising its full-year guidance. The price action reflects a classic sell-the-news reaction after a strong initial move.

Oscar Health (OSCR) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Oscar Health, Inc. (OSCR) Q2 Earnings Beat Estimates

Oscar Health (OSCR) delivered earnings and revenue surprises of +155.81% and -0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook

Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2026 and updates to its full year 2026 guidance. Oscar delivered record profitability in the first half of the year and we are raising our full-year 2026 guidance, said...

Best Growth Stocks to Buy for August 6th

SANM, OSCR and PENN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6th, 2026.

Octave Specialty Group to Report Q2 Earnings: What to Expect

Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.

Will Prudential Financial Pull Off a Surprise This Earnings Season?

PRU's Q2 results are expected to reflect strength in Retirement, Individual Life and PGIM despite pressure in Group Insurance. 

Assurant Set to Report Q2 Earnings: What's in the Cards?

AIZ's Q2 results are expected to benefit from growth in Global Housing and Global Lifestyle, supported by higher premiums and investment income.

Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth

Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $30.57, marking a -2.64% move from the previous day.

Oscar Health, Inc. (OSCR) Recently Broke Out Above the 20-Day Moving Average

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

$OSCR Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.20 up 234.83% YoY
• Reported revenue of $4.88B up 70.40% YoY
• Oscar Health, Inc. updated its full-year 2026 outlook, projecting total revenue between $18.7 billion and $19.0 billion, a medical loss ratio of 81.5% to 82.5%, and earnings from operations of $500M-$700M.

Stocktwits

Oscar Health Inc - Ordinary Shares - Class A

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.20 up 234.83% YoY
• Reported revenue of $4.88B up 70.40% YoY
• Oscar Health, Inc. updated its full-year 2026 outlook, projecting total revenue between $18.7 billion and $19.0 billion, a medical loss ratio of 81.5% to 82.5%, and earnings from operations of $500M-$700M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Equity

Extremely Bullish Sentiment

OSCR health stock price, news, financials, forum, discussion, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

OSCR Health Stock Price Today, News, Analysis and Trading Ideas

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits Polls

Investors express frustration as positive earnings beats lead to significant price drops rather than expected rallies.

Long-term bulls view recent volatility as a bargain-hunting opportunity for this growth-oriented healthcare stock.

Traders increasingly speculate that market makers and heavy short pressure are manipulating price action to flush out retail positions.

Bulls remain focused on revenue growth and potential AI integration, suggesting future price targets well above current levels.

Current Price	$26.72
Prev Close	$30.11
Open	$27.56
Dividend Yield	0.00%
50-Day Moving Average	$28.41
Beta	1.16
Avg. Volume	4.6M
PE Ratio	-49.39

52-Week High	$33.10
52-Week Low	$10.69
Market Capitalization	$9.08B
EPS (Annual)	-$1.69
Price to Book	5.41
Revenue Per Employee	$5.08M

Feed

News

Sentiment

Earnings

Fundamentals

Info